Residential Retreat for Veterans and First-responders

April 4, 2022 updated by: Valhalla Project Niagara

Examining the Efficacy and Feasibility of a Residential Retreat Program for PTSD in First-responders and Veterans: A Non-randomized Controlled Study

The purpose of this study is to determine the potential efficacy and feasibility of a residential retreat program to address PTSD symptoms in Veterans and First-responders

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

After obtaining written consent, participants will complete their program as they had previously intended. Each wave of the residential retreat program will last 5 days. During the program, participants will complete the study questionnaires. They will complete these questionnaires again 1 month after the completion of the program. As a control, individuals completing the program in the online format will also be asked to provide written consent and will complete the questionnaires during the program and 1-month after its completion.

Study Type

Observational

Enrollment (Anticipated)

70

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

These are individuals who are veterans of the military of first-responders, who have also been diagnosed with PTSD.

Description

Inclusion Criteria:

  • Diagnosis of PTSD, being a military veteran or first-responder, awareness of treating physician about program attendance

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Residential Cohort
Those completing the program in a residential context
The program consists of psychoeducational material regarding PTSD, demonstration of various stress management techniques, and social cohesion activities
Other Names:
  • demonstration of stress management techniques
  • social cohesion activities
Online Cohort
Those completing the program online
The program consists of psychoeducational material regarding PTSD, demonstration of various stress management techniques, and social cohesion activities
Other Names:
  • demonstration of stress management techniques
  • social cohesion activities

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Symptom Management of PTSD Using the Perceived Medical Condition Self-Management Scale
Time Frame: 1-month after completion of the program
determining the potential efficacy of the residential program for improving symptom management. The scale is adapted to reflect participants management of their PTSD symptoms. Score ranges from 8 to 40. Higher scores indicate better management.
1-month after completion of the program
Drop-out rate in the Residential Program
Time Frame: at the end of the 5-day residential program for the residential cohort
Determining the extent of treatment drop-out in the Residential Program
at the end of the 5-day residential program for the residential cohort
Symptoms of PTSD Indicated by the PTSD Checklist for DSM-5 scale.
Time Frame: 1-month after completion of the program
determining the potential efficacy of the residential program for improving PTSD symptoms. Scores range from 0 to 80. Higher scores indicate more symptoms of PTSD.
1-month after completion of the program
Interpersonal and Intrapersonal Functioning Using the Brief Inventory of Psychosocial Functioning (B-IPF)
Time Frame: 1-month after the completion of the program
determining the potential efficacy of the residential program for improving interpersonal and intrapersonal functioning (e.g., relationship with family, ability to manage daily tasks, etc.). Scores range from 0 to 42. Higher scores indicate more problems and lower functioning.
1-month after the completion of the program
Drop-out rate in the Online Program
Time Frame: at the end of the 2 month online program for the online cohort.
Determining the extent of treatment drop-out in the Online Program
at the end of the 2 month online program for the online cohort.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jaan Reitav, PhD, C.Psych, Canadian Memorial Chiropractic College

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

March 27, 2022

Primary Completion (Anticipated)

November 21, 2022

Study Completion (Anticipated)

November 21, 2023

Study Registration Dates

First Submitted

March 3, 2022

First Submitted That Met QC Criteria

April 4, 2022

First Posted (Actual)

April 5, 2022

Study Record Updates

Last Update Posted (Actual)

April 5, 2022

Last Update Submitted That Met QC Criteria

April 4, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 2650

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

De-identified data may be available upon request by other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on PTSD

Clinical Trials on psychoeducation

Subscribe